Neural Correlates of Depressive Symptoms in Smokers - A Systematic Review of Imaging Studies

Imagem de Miniatura
Arquivos
art_GONZALEZ_Neural_Correlates_of_Depressive_Symptoms_in_Smokers_A_2017.PDF (879.71 KB)
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Autores
GONZALEZ, Michele de Oliveira
GOUDRIAAN, Anna E.
PERICO, Cintia de Azevedo-Marques
CAMPOS, Marcela Waisman
BHUGRA, Dinesh
Citação
SUBSTANCE USE & MISUSE, v.52, n.14, p.1809-1822, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
This review aims to summarize neuroimaging studies in order to better understand the neural correlates of depressive symptoms in tobacco smokers. Using the keywords depressive OR depression AND tobacco OR nicotine OR smok(*) OR cigarette AND neuroimage OR magnetic resonance OR smri OR structural magnetic resonance OR fmri OR functional magnetic resonance OR pet OR positron emission tomography, literature search was conducted in PubMed, Web of Science and PsycINFO databases. The first and the last author read the abstracts of all the studies found in the search (n = 179). The inclusion and exclusion criteria were applied and 150 articles were excluded. Then, both authors assessed the remaining 29 studies for eligibility and 16 studies were included in the present review. In the phase of active/chronic smoking, depressive symptoms are characterized as comorbidity related to an enhancement of dopamine release, and smokers have decreased Monoamine oxidase A (MAO-A). Stimuli-related functional magnetic resonance imaging (Stimuli-fMRI) studies also show that there is a positive correlation between the level of depressive symptoms and a greater response to general negative stimuli in active/chronic smokers. In the withdrawal phase, depressive symptoms are related to the withdrawal syndrome and increased MAO-A. Stimuli-fMRI studies show that there is a negative correlation between level of depressive symptoms and reactivity to negative stimuli in recent abstinent smokers. Major areas of the reward system such as the striatum and areas related to impulse control are activated to a greater extent in depressive smokers compared to non-depressed smokers.
Palavras-chave
Tobacco use disorder, nicotine dependence, major depressive disorder, neuroimaging, comorbidity, dual diagnosis
URI
https://observatorio.fm.usp.br/handle/OPI/25661
Referências
  1. BACHER I, 2011, 2011, V68, P817
  2. BAEK JH, 2013, 2013, V150, P1158
  3. BALLMAIER M, 2004, 2004, V161, P99
  4. BAXTER LR, 1989, 1989, V46, P243
  5. Bertrand D, 2010, 2010, V12, P463
  6. BLOND BN, 2012, 2012, V14, P340, DOI 10.1111/J.1399-5618.2012.01015.X
  7. BRODY AL, 2004, 2004, V55, P77, DOI 10.1016/S0006-3223(03)00610-3
  8. Brody AL, 2009, BIOL PSYCHIAT, V66, P898, DOI 10.1016/j.biopsych.2009.06.011
  9. BROWN C, 2000, 2000, V30, P15
  10. BUSTO U, 2009, 2009, V63, P681, DOI 10.1002/SYN.20646
  11. Castaldelli-Maia JM, 2014, INT REV PSYCHIATR, V26, P515, DOI 10.3109/09540261.2014.928272
  12. Castaldelli-Maia JM, 2013, REV BRAS PSIQUIATR, V35, P338, DOI 10.1590/1516-4446-2012-0907
  13. COSGROVE K, 2012, 2012, V69, P418
  14. Courtney KE, 2016, ADDICT BIOL, V21, P3, DOI 10.1111/adb.12314
  15. DALBY R, 2010, 2010, V40, P1389, DOI 10.1017/S0033291709991656
  16. DANIELSON K, 2014, 2014, V68, P45, DOI 10.1002/SYN.21715
  17. DEASIS JM, 2001, 2001, V158, P1321
  18. EGERTON A, 2010, 2010, V50, P260, DOI 10.1016/J.NEUROIMAGE.2009.11.077
  19. ESTERLIS I, 2009, 2009, V63, P1089, DOI 10.1002/SYN.20688
  20. ESTERLIS I, 2013, 2013, V18, P370, DOI 10.1111/J.1369-1600.2011.00403.X
  21. FERREIRA M, 2002, 2002, V22, P2764
  22. FOWLER JS, 1996, 1996, V93, P14065
  23. FROELIGER B, 2012, 2012, V220, P707, DOI 10.1007/S00213-011-2522-Y
  24. Froeliger B, 2011, 2011, V17, P668
  25. GOTLIB IH, 2008, 2008, V17, P159
  26. Goudriaan AE, 2010, ADDICT BIOL, V15, P491, DOI 10.1111/j.1369-1600.2010.00242.x
  27. HO P, 2013, 2013, V212, P216, DOI 10.1016/J.PSCYCHRESNS.2012.04.005
  28. Jones HA, 2015, J DUAL DIAGN, V11, P56, DOI 10.1080/15504263.2014.992588
  29. KOOB G, 2010, 2010, V35, P217, DOI 10.1038/NPP.2009.110
  30. KUSHNIR V, 2013, 2013, V16, P997, DOI 10.1017/S1461145710000696
  31. LASSER K, 2000, 2000, V284, P2606
  32. Lawrence D., 2005, BMC PUBLIC HEALTH, V11, P256
  33. LEROY C, 2009, 2009, V29, P86, DOI 10.1097/JCP.0B013E31819E98F
  34. LEVENTHAL AM, 2013, 2013, V133, P324, DOI 10.1016/J.DRUGALCDEP.2013.06.015
  35. LIM SS, 2012, 2013, V380, P2224
  36. LOH EW, 1999, 1999, V4, P539
  37. LOUGHEAD J, 2013, 2013, V18, P732, DOI 10.1111/J.1369-1600.2011.00324.X
  38. MAYBERG HS, 2003, 2003, V65, P193, DOI 10.1093/BMB/65.1.193
  39. MENOSSI HS, 2013, 2013, V27, P921, DOI 10.1007/S40263-013-0092-8
  40. MINEUR YS, 2010, 2010, V31, P580, DOI 10.1016/J.TIPS.2010.09.004
  41. Moher D, PLOS MED, V6
  42. NORTHOFF G, 2013, 2013, V23, P133, DOI 10.1016/J.CONB.2012.08.004
  43. PERGADIA M, 2004, 2004, V29, P665, DOI 10.1016/J.ADDBEH.2004.02.009
  44. RIGUCCI S, 2010, 2010, V11, P165, DOI 10.3109/15622970903131571
  45. RUHE H, 2009, 2009, V36, P841, DOI 10.1007/S00259-008-1057-X
  46. SAKAI H, 2013, 2013, V13, P10, DOI 10.1186/1472-6874-13-10
  47. SCHNEIDER G, 2013, 2013, V38, P2083, DOI 10.1016/J.PSYNEUEN.2013.03.016
  48. SHULMAN KI, 2013, 2013, V27, P789, DOI 10.1007/S40263-013-0097-3
  49. SOIZA RL, 2008, 2008, V65, P239, DOI 10.1016/J.JPSYCHORES.2008.05.021
  50. SONG MS, 2013, 2013, V44, P118, DOI 10.1016/J.PNPBP.2013.02.001
  51. STALEY J, 2001, 2001, V41, P275
  52. SUTHERLAND MT, 2013, 2013A, V74, P538, DOI 10.1016/J.BIOPSYCH.2013.01.035
  53. SUTHERLAND MT, 2013, 2013B, V228, P143, DOI 10.1007/S00213-013-3018-8
  54. SWEITZER MM, 2012, 2012, V123, pS59, DOI 10.1016/J.DRUGALCDEP.2012.01.017
  55. TOTH E, 1992, 1992, V17, P265
  56. VERSACE F, 2014, 2014, V16, P697, DOI 10.1093/NTR/NTT214
  57. WANG Z, 2007, 2007, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007
  58. WHITEFORD HA, 2013, 2010, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
  59. Wu LT, 1999, AM J PUBLIC HEALTH, V89, P1837, DOI 10.2105/AJPH.89.12.1837
  60. Zhang X., 2011, FACTORS UNDERLYING P
  61. World Health Organization, 2011, WHO REP GLOB TOB EP

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - LIM/23
Artigos e Materiais de Revistas Científicas - ODS/03